Dehydroepiandrosterone sulfate plasma levels correlate with lung function, muscle mass and physical performance in fibrotic interstitial lung disease

S. Guler (Vancouver, Canada), S. Hur (Vancouver, Canada), S. Lear (Burnaby, Canada), P. Camp (Vancouver, Canada), P. Wilcox (Vancouver, Canada), J. Leung (Vancouver, Canada), C. Ryerson (Vancouver, Canada)

Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Session: What is new in idiopathic interstitial pneumonias?
Session type: Poster Discussion
Number: 5234
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Guler (Vancouver, Canada), S. Hur (Vancouver, Canada), S. Lear (Burnaby, Canada), P. Camp (Vancouver, Canada), P. Wilcox (Vancouver, Canada), J. Leung (Vancouver, Canada), C. Ryerson (Vancouver, Canada). Dehydroepiandrosterone sulfate plasma levels correlate with lung function, muscle mass and physical performance in fibrotic interstitial lung disease. 5234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dehydroepiandrosterone sulfate plasma levels correlate with lung function in patients with fibrotic interstitial lung disease in two independent cohorts.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Total desmosines in plasma and urine correlate with lung function
Source: Eur Respir J 2012; 39: 839-845
Year: 2012



Correlation of physical fitness with peripheral muscle strength, physical activity levels and lung function in patients with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients
Source: Eur Respir J 2003; 21: 789-794
Year: 2003



The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease
Source: Annual Congress 2012 - The latest insights in integrated care
Year: 2012


KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Does lung function predict response to therapy in PAH associated with connective tissue disease?
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012


Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006


Corticosteroids affect skeletal muscle strength in mild level of breathlessness of patients with interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012


Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue?
Source: Virtual Congress 2020 – Exploring respiratory function
Year: 2020




Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012


Nintedanib inhibits contractile activity of lung myofibroblasts in a cellular model of scleroderma associated pulmonary fibrosis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018




Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Aerobic exercise can impair lung fibrotic and functional response in a model of bleomycin-induced lung fibrosis: a time-dependent effect
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017

Respiratory muscle function in interstitial lung disease
Source: Eur Respir J 2013; 42: 211-219
Year: 2013



Exercise tolerance in interstitial and chest wall disorders
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005